Related by context. All words. (Click for frequent words.) 68 Glioblastoma multiforme GBM 67 squamous cell lung cancer 66 renal cell carcinomas 66 GISTs 66 osteosarcomas 66 neuroblastomas 66 hepatocellular carcinomas 66 astrocytomas 66 neuroendocrine cancers 66 metastatic melanomas 65 pilocytic astrocytomas 65 epithelial tumors 65 Glioblastomas 65 breast carcinomas 65 Acute myeloid leukemia 65 ADPKD 65 adenocarcinomas 64 Gliomas 64 Gleevec resistant 64 HER2 positive cancers 64 metastatic bladder 64 differentiated thyroid 64 K ras mutations 64 hypermethylated 64 hepatoma 64 Glioblastoma multiforme 63 pancreatic endocrine 63 lymphoid organs 63 leukemias lymphomas 63 seminomas 63 mesotheliomas 63 lymphoid tissues 63 skeletal metastases 63 metastatic tumors 63 GIST tumors 63 basal cell carcinoma BCC 63 pituitary adenomas 63 clade B 63 nonmelanoma skin cancers 63 medulloblastomas 63 intracranial tumors 63 hamartomas 63 mucinous 63 hyperplastic 63 carcinoid 62 Basal cell 62 serous ovarian cancer 62 PCNSL 62 histologic subtype 62 castrate resistant 62 BMPR2 62 Leukemias 62 colorectal adenocarcinoma 62 nasopharyngeal carcinoma 62 childhood leukemias 62 HER2 overexpression 62 mutated p# 62 Epstein Barr virus EBV 62 histologies 62 Glioblastoma Multiforme GBM 62 carcinoid tumors 62 lymphocytic 62 Hurthle cell 62 acute myeloid 62 recurrent glioblastoma multiforme 62 squamous cell carcinoma SCC 62 precursor lesions 62 neoplasms 62 nasopharyngeal cancer 62 malignant neoplasm 61 germline mutations 61 Squamous 61 IDH1 mutation 61 p# deficient 61 HBeAg negative 61 metastatic neuroendocrine tumors 61 anaplastic astrocytoma AA 61 hypereosinophilic syndrome 61 mutated K ras 61 oral squamous cell 61 papillary renal cell carcinoma 61 nonmetastatic 61 cholangiocarcinoma 61 HER2 amplification 61 nonsmall cell lung cancer 61 gastric carcinoma 61 oncoproteins 61 Leydig cell 61 cervical lymph nodes 61 M. pneumoniae 61 lung cancer NSCLC 61 supratentorial 61 metastatic lesions 61 micrometastases 61 autosomal recessive disease 61 EGFR mutation positive 61 bronchogenic carcinoma 61 ccRCC 61 neoplastic 61 anaplastic 61 BCR ABL mutations 61 missense mutations 61 allogeneic HSCT 61 lung carcinomas 61 IgA deficiency 61 IDH1 gene 61 lymphomas 61 ependymomas 61 malignant brain 61 Th2 cytokines 61 Basal cell carcinoma 61 hematopoietic cells 61 Anaplastic 61 tumor metastases 61 GBM tumors 61 vWD 61 GRNOPC1 contains 60 orchitis 60 colorectal carcinoma 60 Acute lymphoblastic leukemia 60 CLL cells 60 metastatic brain tumor 60 candidemia 60 CYT# potent vascular disrupting 60 Squamous cell 60 Gorlin syndrome 60 relapsed MM 60 meningiomas 60 Endometrial cancer 60 Papillary 60 PTEN gene 60 Carcinoid tumors 60 atherosclerotic lesions 60 chromosomal aberrations 60 surgically resectable 60 sporadic ALS 60 HNSCC 60 oligodendroglioma 60 myeloid 60 cellular prion protein 60 pulmonary metastases 60 cytotoxic therapies 60 etiologic agent 60 Cholangiocarcinoma 60 neuroendocrine carcinoma 60 thyroid carcinoma 60 MGUS 60 somatic mutations 60 radiosensitive 60 Brain metastases 60 familial ALS 60 grade gliomas 60 endocrine therapies 60 neoplastic cells 60 malignant prostate 60 hematologic disorders 60 promoter hypermethylation 60 tumoral 60 HER2 expression 60 esophageal gastric 60 malignant fibrous histiocytoma 60 gastrointestinal stromal tumors GISTs 60 HbF 60 IGFBP 3 60 IgA antibodies 60 replicon 60 NOTCH1 60 histological subtype 60 ANCA associated 60 renal tumors 60 tumor subtypes 60 nonmelanoma 60 herpesviruses 60 lymphoid 60 Barrett mucosa 60 breast pancreatic 60 circulating endothelial cells 60 asymptomatic carriers 60 Chronic lymphocytic leukemia 60 opportunistic pathogens 60 basal cell nevus syndrome 60 pancreatic adenocarcinoma 60 demyelinating 60 Chronic myeloid leukemia 60 recurrent glioblastoma multiforme GBM 60 anti angiogenic agents 60 unmutated 60 GPC5 60 Immunohistochemical analysis 59 metaplasia 59 PNET 59 myelofibrosis polycythemia vera 59 bladder cancers 59 BRAF gene 59 invasive ductal breast cancer 59 neoplasm 59 RASSF1A 59 BRCA1 BRCA2 59 BCR ABL protein 59 molecular abnormalities 59 lymphoid cells 59 gastric adenocarcinoma 59 NKX#.# 59 noncancerous cells 59 cathepsins 59 hematologic toxicity 59 KRAS oncogene 59 lymphomas leukemias 59 A. fumigatus 59 coagulation disorders 59 cisplatin resistant 59 OGG1 59 SOD2 gene 59 oligodendrogliomas 59 germline mutation 59 Streptococcus pyogenes 59 malignant lymphomas 59 colorectal gastric 59 lymphoma subtypes 59 cytopathic 59 intestinal metaplasia 59 pancreatic prostate 59 neuroblastoma tumors 59 pheochromocytoma 59 CMV infections 59 chemically inactivated 59 paragangliomas 59 Umbilical cord stem cells 59 PIK3CA 59 p# mutations 59 breast carcinoma 59 glioblastoma tumors 59 prophylactic cranial irradiation 59 mutated KRAS gene 59 squamous cell cancers 59 neurofibromas 59 unresectable tumors 59 urothelial carcinoma 59 Ribavirin causes 59 androgen receptor AR 59 synovial sarcoma 59 haematopoietic 59 chemokine receptors 59 TTR gene 59 prostate epithelial cells 59 radiosensitivity 59 staphylococci 59 adenomatous 59 WT1 59 leukaemias 59 immunocompetent 59 mutated KRAS 59 hematopoietic cancers 59 pDCs 59 prostate carcinoma 59 malignant pleural mesothelioma 59 HER2 positivity 59 p# activation 59 sarcomatoid 59 ano genital warts 59 lung adenocarcinomas 59 molecular subtypes 59 lung adenocarcinoma 59 basal cell skin 59 haematopoietic stem cell 59 benign neoplasms 59 papillary carcinoma 59 allogeneic bone marrow 59 subependymal giant cell 59 immunopathology 59 JAK2 enzyme 59 glioblastoma multiforme GBM 59 EBV infection 59 ALI ARDS 59 invasive carcinoma 59 grade cervical intraepithelial 59 acute lymphoid leukemia 59 chronic HBV infection 59 stage IIIA 59 endostatin 59 Synovial sarcoma 59 glioma cells 59 HPV subtypes 59 bronchial epithelial cells 59 liver metastasis 59 seminoma 59 antimetabolites 59 bladder carcinoma 59 urothelial cancer 59 myeloproliferative diseases 58 CIN3 58 Malignant glioma 58 BRCA deficient 58 trophoblast cells 58 transgenic rats 58 malignant pancreatic 58 testicular tumors 58 alveolar rhabdomyosarcoma 58 benign moles 58 neoplasias 58 cranial irradiation 58 PBMCs 58 CEACAM1 58 epithelioid 58 colorectal liver metastases 58 isotypes 58 Madin Darby canine 58 breast cancer subtypes 58 antiangiogenic drugs 58 carcinoids 58 tumors GIST 58 carcinomas 58 NNRTI resistance 58 promoter methylation 58 follicular thyroid cancer 58 PDGFRA 58 prostate adenocarcinoma 58 ALK mutations 58 syngeneic 58 immunosuppressed patients 58 LRP5 58 vivax 58 ERBB2 58 overexpress 58 embryonal rhabdomyosarcoma 58 chemoresistant 58 lymphoblasts 58 EGFRvIII 58 lobular carcinomas 58 metastatic liver 58 elevated LDH 58 NF kB pathway 58 Pancreatic neuroendocrine tumors 58 TMPRSS2 ERG 58 Prion proteins 58 invasive lobular 58 UGT#A# * 58 neovascularisation 58 pre malignant lesions 58 malignant pheochromocytoma 58 lung metastases 58 colonic mucosa 58 recombinants 58 renal pelvis 58 lysosomal storage diseases 58 curative therapy 58 medulloblastoma tumors 58 FUS1 58 cytogenetic abnormalities 58 FLT3 58 Human papillomavirus 58 oesophageal adenocarcinoma 58 gastrointestinal stromal tumors 58 vestibular schwannomas 58 primitive neuroectodermal tumors 58 de novo mutations 58 completely resected 58 Myelodysplastic syndrome 58 Candida infection 58 Adjuvant chemotherapy 58 SSc 58 Lymphocytic 58 HER2 receptor 58 Acute myelogenous leukemia 58 BRAF mutations 58 PDGFR 58 telomerase inhibition 58 endometrial ovarian 58 LHRH receptor positive 58 hepatocellular cancer 58 mutant p# 58 Recurrences 58 MYCN amplification 58 Surgical resection 58 Valproic acid 58 TMPRSS2 ERG fusion 58 papillomas 58 basal cell carcinomas 58 mutated BRAF gene 58 Colon polyps 58 intracranial hemorrhage ICH 58 IFNs 58 castration resistant 58 RAS mutations 58 immunomodulatory properties 58 malignant ovarian 58 paraganglioma 58 common hematologic malignancy 58 superficial bladder cancer 58 GBA mutations 58 localized prostate 58 precancerous condition 58 varicella infection 58 sarcomas 58 IDH1 58 prostate carcinomas 58 squamous cell 58 teratoma 58 HBx 58 genomic alterations 58 chlamydial 58 Benign tumors 58 EGFR tyrosine kinase inhibitors 58 untreated celiac disease 58 Cryptococcus neoformans 58 Malignant mesothelioma 58 adeno associated viruses 58 proliferative disorders 58 MLL2 58 thymectomy 58 Immunohistochemical staining 58 Glioma 58 haematologic 58 TNF blocker therapy 58 TGFBR1 * 6A 58 granulocytes 58 metastatic colorectal 58 Wilms tumors 58 PrPSc 58 synthetic analogues 58 leukemic cells 58 subtyped 58 activating mutations 58 medulloblastoma 58 B7 H3 58 NKT cells 58 MALT lymphoma 58 fibrocytes 58 extramedullary 58 leiomyomas 58 salivary proteins 58 precancerous cervical lesions 58 basal cell cancers 58 gliomas 58 Neisseria 58 heparanase 58 imatinib resistance 58 Glioblastoma 58 nutlin 3a 58 glucocorticoid receptors 58 Medullary thyroid cancer 57 spontaneously regress 57 gastrointestinal stromal tumor 57 humoral responses 57 adenomatous polyps 57 hepatitis C genotype 57 familial pancreatic cancer 57 renal cortical 57 EGFR inhibitors 57 abnormal cytology 57 anthracycline chemotherapy 57 epithelial cancers 57 immunoreactivity 57 metastatic renal 57 inherited mutations 57 activated microglia 57 Opportunistic infections 57 acute leukemias 57 mda 7 57 Plasmodium vivax 57 lung pancreatic 57 normal karyotype 57 mucosal inflammation 57 ependymoma 57 Protease inhibitors 57 MAPK pathway 57 cells multiply uncontrollably 57 bleomycin 57 adrenocortical cancer 57 hepatocellular carcinoma 57 post transplant lymphoproliferative 57 X4 viruses 57 pancreatic cancers 57 colorectal tumors 57 GCase 57 granzyme B 57 T#I [002] 57 pancreatic lung 57 myeloma cells 57 gastric carcinomas 57 premalignant 57 metastatic prostate 57 systemic amyloidosis 57 S. maltophilia 57 KIT mutations 57 motor neuron degeneration 57 squamous histology 57 RKIP 57 HCV infections 57 plasmacytoid 57 nonmalignant 57 F#del 57 JAK mutations 57 Renal cell carcinoma 57 leucopenia 57 invasive ductal 57 FGFs 57 monogenic 57 cervical carcinoma 57 hepatic metastases 57 ELISPOT assay 57 CpG ODNs 57 rifamycins 57 hematological malignancy 57 antiproliferative effects 57 CMV infection 57 myeloproliferative neoplasms 57 gastric cancers 57 IDH1 mutations 57 liver metastases 57 Li Fraumeni 57 nodal metastasis 57 astrocytoma 57 immunodeficiency 57 smoldering myeloma 57 TRAIL induced apoptosis 57 PARP inhibition 57 colorectal tumor 57 ALK gene 57 advanced adenomas 57 potent inducer 57 MLH1 57 CD#c 57 EGFR protein 57 S. aureus infection 57 kidney urologic 57 inducible nitric oxide synthase 57 mTOR inhibitors 57 infiltrative 57 myelomas 57 tryptase 57 leukemia AML 57 lymphoid tumors 57 chromosomal rearrangement 57 renal carcinoma 57 metastasise 57 uterine tumors 57 MAGE A3 57 isotype 57 K#N 57 E#F# 57 malignant gliomas 57 Sjögren syndrome 57 coreceptor 57 SPINK1 57 FLT3 mutations 57 HepG2 cells 57 activated lymphocytes 57 S. aureus isolates 57 uveal melanoma 57 EoE 57 transfusion syndrome 57 intravenous bisphosphonates 57 bladder ovarian 57 Langerhans cell histiocytosis 57 B Cell Lymphoma 57 EphA2 57 COL#A# 57 Myelodysplastic syndromes MDS 57 baseline LDH 57 glial tumors 57 LRAT 57 HER2 positive breast 57 microdeletions 57 NOMID 57 Epstein Barr Virus EBV 57 metastatic gastric 57 bacterium Neisseria meningitidis 57 Stat5 57 metastatic malignant melanoma 57 Peritoneal mesothelioma 57 ovarian endometrial 57 retroviral vectors 57 transgene expression 57 heavily pretreated 57 MSH2 57 Cathepsin B 57 malignant lymphoma 57 Thyroid nodules 57 metastatic cancers 57 thymoma 57 distinct subtypes 57 BALB c mice 57 hormone receptor negative 57 somatostatin receptors 57 testicular cancers 57 Pneumocystis carinii pneumonia 57 meningeal 57 KRAS mutations 57 chronic granulomatous disease 57 removed laparoscopically 57 nonnucleoside reverse transcriptase inhibitors 57 nonalcoholic steatohepatitis NASH 57 coagulase negative staphylococci 57 pharmacologic intervention 57 Eosinophils 57 Malignant tumors 57 hemorrhagic cystitis 57 haematologic malignancies 57 metastatic uveal melanoma 57 bone marrow lymph nodes 57 Metastases 57 Immune responses 57 GNAQ 57 Toxicities 57 Glucocorticoids 57 bronchoalveolar 57 eotaxin 57 peritoneal carcinomatosis 57 ovarian breast 57 trophoblasts 57 IFNg 57 immunized mice 57 CD# mAb 57 malignant cancerous 57 myeloproliferative 57 radiographic findings 57 non mutated KRAS 57 Aortic stenosis 57 operable breast cancer 57 elevated triglyceride levels 57 EGFR blockers 57 cranial radiation 57 deletion 5q 57 nephrogenic 57 pneumocystis 57 leucocytes 57 Histologically 57 spongiform encephalopathies 57 follicular lymphomas 57 corticosteroid therapy 57 Pleural mesothelioma 57 NF1 57 neurofibroma 57 fibroma 57 neuroendocrine tumors 57 infarcts 57 invasive ductal carcinoma 57 Mitomycin C 57 #q# deletion 57 vWF 57 pathogenic mutations 57 myopathies 57 HLA B# 57 Philadelphia Chromosome Positive 57 EGFR mutation 57 metastatic lymph nodes 57 frequently benign tumor 57 immunodeficiency disorders 57 Treg cell 57 Autoimmune hepatitis 57 E. faecalis 57 adjuvant cisplatin 57 cell carcinoma 57 HER2 positive tumors 57 resistant isolates 57 sCJD 57 KRAS mutations occur 57 anal lesions 57 chronic eosinophilic leukemia 57 p#INK#a 57 modifier genes 56 squamous cell histology 56 eIF 4E 56 leiomyoma 56 CTEPH 56 gastrointestinal cancers 56 allogenic 56 mouse testes 56 motor neuron diseases 56 superantigens 56 transfusion transmitted 56 nodular melanoma 56 radioimmunotherapy RIT 56 endometrioid 56 recurrent NSCLC 56 ABCB1 gene 56 hepatorenal syndrome 56 histologically proven 56 hepatocellular carcinoma HCC 56 familial clustering 56 systemic scleroderma 56 diagnose coronary artery 56 colorectal polyp 56 enteroviral infection 56 uPAR 56 lamivudine resistant 56 IDH mutations 56 colorectal carcinomas 56 noncardiac 56 carotid plaques 56 Chronic pancreatitis 56 hematologic malignancy 56 breast endometrial 56 CDKN2A 56 lymphoproliferative disease 56 H. influenzae 56 PTPN# 56 poor metabolizers 56 preferentially bind 56 malignant ascites 56 VEGF receptor 56 endocrine tumors 56 squamous 56 serogroup B 56 Hepatocellular Carcinoma HCC 56 epigenetic alterations 56 Waldenstrom macroglobulinemia 56 CD4 + T lymphocytes 56 Upregulation 56 Wegener granulomatosis 56 cell lymphomas 56 NMIBC 56 liver scarring 56 myeloablative 56 C. pneumoniae 56 lymphoproliferative disorders 56 IPAH 56 alveolar epithelial cells 56 P. falciparum malaria 56 cisplatin chemotherapy 56 ASCUS 56 Helicobacter 56 vaginal lesions 56 haematopoietic stem cells 56 enterocolitis 56 essential thrombocythemia ET 56 metastatic tumor 56 ovarian carcinoma 56 drugable targets 56 Glioblastoma Multiforme 56 malignant lesions 56 advanced hepatocellular carcinoma 56 benign nodules 56 P aeruginosa 56 polycystic kidneys 56 bacteria Pseudomonas 56 PTEN protein 56 leukemic stem cells 56 unstable detrusor muscle 56 osteoblastic 56 UGT#B# 56 endometrial hyperplasia 56 leukoencephalopathy 56 monoclonal gammopathy 56 carcinoid tumor 56 histone deacetylases 56 interferon IFN 56 ERK signaling 56 Enzastaurin 56 protein kinase C 56 ductal breast cancer 56 cirrhosis liver failure 56 autoreactive 56 Epidermal Growth Factor Receptor 56 Chronic lymphocytic leukemia CLL 56 vaccinees 56 splice variants 56 xenograft tumors 56 chemokine receptor 56 SOD1 gene 56 micrometastasis 56 mosaicism 56 SGPT 56 Mesenchymal 56 dysplastic lesions caused 56 GSTT1 56 leukemia lymphomas 56 Akt1 56 phosphorylated tau 56 tumor histology 56 cell acute lymphoblastic 56 Akt signaling 56 epithelial ovarian 56 prostate cancer CaP 56 anaplastic lymphoma kinase ALK 56 fluconazole resistant 56 graft dysfunction 56 teratogens 56 hematological disorders 56 Chlamydia trachomatis infection 56 ABCB1 56 hepatitis B infection 56 thymidylate synthase TS 56 adverse cytogenetics 56 microvessels 56 serologic tests 56 granulosa cell 56 narcolepsy cataplexy 56 osteoporotic vertebral compression fractures 56 HSV1 56 alkylating agents 56 IGF1R 56 Leydig cells 56 Circulating tumor cells 56 biochemical abnormalities 56 preoperative chemotherapy 56 miRNA genes 56 erlotinib Tarceva ® 56 brain lesions 56 glutamic acid decarboxylase 56 mycosis fungoides 56 papillary 56 low expressors 56 cytoreduction 56 bacteriuria 56 ORMDL3 56 proto oncogene 56 von Willebrand disease 56 SOD1 56 Cytotoxic 56 MMP inhibitors 56 KCNH2 56 gastrointestinal malignancies 56 N. gonorrhoeae 56 tNOX 56 pathological hallmark 56 endometrial cancers 56 pDC 56 glomerulonephritis 56 precancerous cervical 56 Metastatic 56 pleomorphic 56 mesothelial cells 56 cytomegalovirus retinitis 56 induced anemia 56 brucei 56 lymphocytic leukemia 56 peritoneal cancer 56 aneuploidies 56 Follicular lymphoma 56 histopathologic examination 56 thrombocytopenic patients 56 stratifying patients 56 mutational status 56 International Prognostic Scoring 56 CD# expressing 56 ADAMTS# 56 acid phosphatase PAP 56 gene rearrangements 56 eosinophilic 56 malignant growths 56 System IPSS 56 SMAD4 56 inhibit replication 56 rotaviruses 56 capsular polysaccharide 56 chronic HBV 56 MetAP2 56 Neuroendocrine tumors 56 moderately emetogenic 56 mesangial 56 ZNF# 56 cytolytic 56 hormone refractory 56 pretreatment serum 56 CMV reactivation 56 prostate cancer metastases 56 idiopathic myelofibrosis 56 microsatellite instability 56 Febrile neutropenia 56 glioblastoma tumor 56 NRTI resistance 56 GSTP1 56 kinase inhibition 56 aneuploid cells 56 pancreatic ductal 56 nanomolar 56 HGPIN 56 colorectal neoplasms 56 generalized epilepsy 56 lymphocytosis 56 sonographic diagnosis 56 metachronous 56 pancreatic carcinoma 56 T1c 56 urothelial bladder cancer 56 IgG antibodies 56 adenocarcinoma 56 pancreatic neuroendocrine 56 molecularly defined 56 oligodendrocyte progenitor cells 56 Kinoid 56 parainfluenza virus 56 pituitary adenoma 56 JAK inhibitors 56 mitochondrial toxicity 56 glioma tumors 56 genotypic resistance 56 chlamydial infection 56 Velculescu 56 lymphovascular invasion 56 fibrin deposition 56 node metastases 56 lymphoid tissue 56 Multidrug resistant 56 primary immunodeficiency PI 56 virulence genes 56 noninfectious 56 idiopathic pulmonary arterial hypertension 56 HER2 gene 56 Rimantadine 56 heterotaxy 56 FGFR2 56 pheochromocytomas 56 NOD SCID mice 56 ErbB2 positive 56 human leukocyte antigens 56 JAK2 gene 56 mononuclear cells 56 causative organisms 56 pyelonephritis 56 amenorrhoea 56 synovial cells 56 apoptotic pathway 56 Fas ligand 56 rhinovirus infections 56 somatostatin analogs 56 histone acetylation 56 acute promyelocytic leukemia 56 Brugada syndrome 56 M. genitalium 56 immunohistochemical staining 56 chemo resistant 56 hematopoietic progenitor cells 56 HCV infection 55 serologically 55 cortical dysplasia 55 N Myc 55 CD# + [001] 55 PNH patients 55 TMEM#B 55 MTHFR 55 severe congenital neutropenia 55 peptide antigens 55 beta lactams 55 Malignant gliomas 55 pleural mesothelioma 55 squamous cell carcinomas 55 desmoid tumor 55 chromosomal alterations 55 TNFa 55 CYP #D# 55 HER2 receptors 55 tumor nodules 55 fibrate drugs 55 breast cancer susceptibility genes 55 hamartoma 55 tigecycline 55 germinal center 55 BRCA1 mutation carriers 55 vulvar intraepithelial neoplasia 55 receptor tyrosine kinase inhibitor 55 tumor antigen 55 plasma pharmacokinetics 55 histologically 55 S. suis 55 Basal Cell 55 Meningiomas 55 HCCs 55 apoE 55 Candida species 55 IgG4 55 degenerative neurological diseases 55 griseofulvin 55 Crizotinib 55 BRAF protein 55 GPNMB 55 pneumococci 55 enlarged spleens 55 busulfan 55 IFN gamma 55 Melanomas 55 gonococcal infection 55 hepatic liver 55 glycosylated 55 serotonin receptor 55 Kupffer cells 55 humanised antibody 55 refractory Hodgkin 55 EGFR pathway 55 autopsied brains 55 replicase 55 squamous carcinoma 55 BRAF V#E mutation 55 hemorrhagic complications 55 neoplastic lesions 55 papillary RCC 55 interferon pathway 55 cutaneous melanoma 55 Chlamydia pneumoniae 55 TCF#L# 55 C#Y 55 lysosomal storage disease 55 EGFR mutations 55 TP# gene 55 enteroviral 55 urethritis 55 clinically evaluable